Diant Pharma Inc. — Form C (Regulation Crowdfunding)
Diant Pharma Inc. of Manchester, CT filed a Form C (Regulation Crowdfunding) with the SEC on 2024-12-11. Target raise $124K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2024-12-11
- Form: C
- Accession: 0001665160-24-001794
- Target amount: $124K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 65,957
- Price: $1.8800
- Deadline: 2025-03-12
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0001949139
- Website: www.diantpharma.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2019-07-02
- Address: 130 Utopia Road, Unit 12, Manchester, CT, 06042
- Employees: 9
Financials (as filed)
- Total assets (most recent): $2.2M
- Cash (most recent): $544K
- Revenue (most recent): $1.8M
- Revenue (prior): $540K
- Net income (most recent): $-323K
- Net income (prior): $-322K
- Short-term debt: $119K
- Long-term debt: $122K
People (6)
| Name | Role | Location |
|---|
| Diane Burgess | Board Member | MANCHESTER, CT |
| Antonio Costa | CEO and Board Member | MANCHESTER, CT |
| Antonio Costa | CEO & Board Member | MANCHESTER, CT |
| Maik Jornitz | Board Member | College Station, TX |
| Bryan Kotlarz | CFO | MANCHESTER, CT |
| Abraham Maingi | Board Member | MANCHESTER, CT |
Reg CF filing history (5)
More